GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
1-Year Return
66.36%
This Quarter Return
+18.8%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$1.66B
AUM Growth
+$275M
(+20%)
Cap. Flow
+$67.1M
Cap. Flow
% of AUM
4.04%
Top 10 Holdings %
Top 10 Hldgs %
23.67%
Holding
233
New
36
Increased
109
Reduced
61
Closed
26
Top Buys
| 1 |
WW
WW International
WW
|
$30.6M |
| 2 |
Globant
GLOB
|
$24.8M |
| 3 |
Paycom
PAYC
|
$15.9M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
$14.3M |
| 5 |
Chart Industries
GTLS
|
$13.3M |
Top Sells
| 1 |
Teladoc Health
TDOC
|
$12.8M |
| 2 |
Axon Enterprise
AXON
|
$11M |
| 3 |
ULTI
Ultimate Software Group Inc
ULTI
|
$9.86M |
| 4 |
Evolent Health
EVH
|
$9.83M |
| 5 |
MB
MINDBODY, Inc. Class A Common Stock
MB
|
$9.71M |
Sector Composition
| 1 | Technology | 32.93% |
| 2 | Healthcare | 19.82% |
| 3 | Industrials | 15.24% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Consumer Staples | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Vistra
VST
$61.7B
| $1.34M | 0.08% |
56,786
+9,472
| +20% | +$224K |
|
177
EPAM Systems
EPAM
$9.41B
| $1.34M | 0.08% |
10,800
-200
| -2% | -$24.9K |
|
178
The Joint Corp
JYNT
$163M
| $1.33M | 0.08% |
+161,929
| New | +$1.33M |
|
179
Tyler Technologies
TYL
$24B
| $1.22M | 0.07% |
5,507
-1,025
| -16% | -$228K |
|
|
AKAO
180
DELISTED
Achaogen, Inc.
AKAO
| $1.22M | 0.07% |
+140,861
| New | +$1.22M |
|
|
SOHO
181
Sotherly Hotels
SOHO
$17M
| $1.18M | 0.07% |
169,137
+24,848
| +17% | +$174K |
|
182
Akamai
AKAM
$11.2B
| $1.06M | 0.06% |
+14,505
| New | +$1.06M |
|
|
JNCE
183
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.01M | 0.06% |
131,592
+11,007
| +9% | +$84.3K |
|
184
Fulgent Genetics
FLGT
$675M
| $941K | 0.06% |
227,233
+34,229
| +18% | +$142K |
|
185
Steel Dynamics
STLD
$19.7B
| $859K | 0.05% |
18,691
+12,850
| +220% | +$591K |
|
186
Live Nation Entertainment
LYV
$37.7B
| $745K | 0.04% |
+15,329
| New | +$745K |
|
187
Larimar Therapeutics
LRMR
$347M
| $712K | 0.04% |
5,804
+792
| +16% | +$97.2K |
|
188
LoveSac
LOVE
$297M
| $667K | 0.04% |
+32,155
| New | +$667K |
|
189
LiveRamp
RAMP
$1.86B
| $645K | 0.04% |
+21,521
| New | +$645K |
|
190
Fennec Pharmaceuticals
FENC
$256M
| $595K | 0.04% |
57,002
+9,626
| +20% | +$100K |
|
|
AVEO
191
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $406K | 0.02% |
17,951
+2,513
| +16% | +$56.8K |
|
192
Forte Biosciences
FBRX
$136M
| $396K | 0.02% |
113
+15
| +15% | +$52.6K |
|
193
X4 Pharmaceuticals
XFOR
$78.3M
| $365K | 0.02% |
+559
| New | +$365K |
|
194
Insulet
PODD
$24.5B
| $320K | 0.02% |
+3,734
| New | +$320K |
|
195
Match Group
MTCH
$9.07B
| $316K | 0.02% |
8,166
-5,505
| -40% | -$213K |
|
196
Neogen
NEOG
$1.25B
| $283K | 0.02% |
+7,066
| New | +$283K |
|
197
Neuronetics
STIM
$209M
| $266K | 0.02% |
+10,000
| New | +$266K |
|
198
FirstCash
FCFS
$6.61B
| $252K | 0.02% |
+2,810
| New | +$252K |
|
|
VYNT
199
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $246K | 0.01% |
1,843
+273
| +17% | +$36.4K |
|
200
Haemonetics
HAE
$2.63B
| $229K | 0.01% |
+2,550
| New | +$229K |
|